Pelican Expression News Today

Ligand retains all Pelican commercial royalties and will own 49.9% of Primrose Bio, Inc. as a stand-alone private company with leading technologies in synthetic biologyLigand contributes $15 million in exchange for economic interest in select Primrose programsLigand improves cash expense outlook and raises EPS guida...

/PRNewswire/ -- Primrose Bio, Inc., a stand-alone private biotechnology company focused on developing state-of-the-art discovery and production systems for...

CORPORATE PRESENTATION SEPTEMBER 2023 Nasdaq: LGND ...

CORPORATE PRESENTATION OCTOBER 2023 Nasdaq: LGND ...

2023 Financial Guidance Raised Conference Call Begins at 4:30 p.m. Eastern Time Today ... | May 4, 2023

Operator Good day and thank you for standing by. Welcome to the Ligand Pharmaceuticals Second Quarter Earnings Call. At this time all participants are in a listen-only mode. After the speakers presentation there will be a question and answer session. [Operator Instructions] I would now like to hand the conference over to your first speaker today the Head of Investor Relations, Mr. Simon Latimer. Please go ahead sir. Simon Latimer -- Head of Investor Relations Thank you. Welcome to Ligands seco...

Ligand Pharmaceuticals Inc (LGND) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Ligand Pharmaceuticals Inc (NASDAQ: LGND) Popular Searches Operator Good afternoon, and thank you for standing by. Welcome to the Ligand Pharmaceuticals Quarter One Earnings Call. [Operator Instructions]. After the speakers presentation, there will be a question-and-answer session. [Operator Instructions]. I would now like to h...